Disease | thrombophilia |
Comorbidity | C0026265|mitral valve disease |
Sentences | 2 |
PubMedID- 25115553 | hypercoagulability in mitral valve disease (mvd), a cause of atrial fibrillation (af) and stroke, is potentially due to endothelial damage/dysfunction (marked by circulating endothelial cells [cecs]), platelet activation (soluble p-selectin [spsel], platelet microparticles [pmps], and soluble cd40 [scd40]), and oxidized low-density lipoprotein (oxldl) cholesterol. |
PubMedID- 25169134 | Heme oxygenase derived carbon monoxide and iron mediated plasmatic hypercoagulability in a patient with calcific mitral valve disease. |
Page: 1